Timolol topical - Senju Pharmaceutical

Drug Profile

Timolol topical - Senju Pharmaceutical

Alternative Names: Istalol

Latest Information Update: 03 May 2016

Price : $50

At a glance

  • Originator Senju Pharmaceutical
  • Class Amino alcohols; Antiglaucomas; Antihypertensives; Ischaemic heart disorder therapies; Morpholines; Propanolamines; Small molecules; Thiadiazoles
  • Mechanism of Action Beta-adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Glaucoma; Ocular hypertension

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 06 Jun 2012 ISTA Pharmaceuticals has been acquired by Bausch & Lomb
  • 29 Jul 2004 Launched for Ocular hypertension in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top